Campos, M.I., Vieira, W.D., Campos, C.N., Aarestrup, F.M. and Aarestrup, B.J. (2015) Atorvastatin and Trans-Caryophyllene for the Prevention of Leukopenia in an Experimental Chemotherapy Model in Wistar Rats. Molecular and Clinical Oncology, 3, 825-828.
http://dx.doi.org/10.3892/mco.2015.544

has been cited by the following article:

• TITLE: Risk Factors for Chemotherapy-Induced Leukopenia in Patients with Lung Cancer

  AUTHORS: Hongyan Jin, Xiaoya Chen, Wei He, Qian Liu, Zexiong Wei, Jinjun Li

  KEYWORDS: Chemotherapy-Induced Leucopenia, Risk Factors, Lung Cancer

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.7 No.3, March 18, 2016

  ABSTRACT: Objective: This analysis was conducted to clarify risk factors for chemotherapy-induced leukopenia (CIL) in lung cancer. Methods: A retrospective study was conducted on data from 358 patients with lung cancer who received chemotherapy. Results: Among 358 cases of lung cancer who received chemotherapy, a total of 240 patients experienced CIL, rate was 67%. The demographic data including gender (P = 0.795), age (P = 0.134), presence of selected chronic comorbidities (P = 0.23) were not significantly different in the two groups. The weight loss rate, PS score, sub-normal pre-WBC level, sub-normal pre-PLT level, and the cycle of chemotherapy were significantly different between the groups (P